Acumen Pharmaceuticals

Acumen reveals late-stage clinical trial plans in early Alzheimer’s disease
Clinical Trials Arena
Tue, 02/28/23 - 11:02 am
Acumen Pharmaceuticals
clinical trials
Alzheimer's disease
ACU193
monoclonal antibodies
All in on amyloid, Acumen Pharma’s IPO raises $160M for Alzheimer’s drug R&D
MedCity News
Fri, 07/2/21 - 10:54 am
Acumen Pharmaceuticals
IPOs
Alzheimer's disease